New SEC Form D filing
Altrartis Therapeutics Inc., 2026-10-22
A new SEC Form D private-offering notice from New York, NY, a $10,999,977 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Altrartis Therapeutics Inc. Verified via SEC Form D
Biotech developing novel MDMA prodrug and psilocybin-based compounds for mental health therapeutics
New filing yesterdayFiled to raise $10,999,977First money in 2026-08-12Raised so far $10,999,977HQ (as filed) New York, NYSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Named in the filing 2 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Upright Education, Inc., 2026-10-23, $2.8M, New York, NY
- Medical 21, Inc., 2026-10-23, $20M, Plymouth, MN
- Arkaea Media Group Inc., 2026-10-21, $4.1M, New York, NY
- OS Therapies Inc, 2026-10-23, $12.3M, Grasonville, MD
- Ritually, Inc., 2026-10-21, $1.5M, New York, NY
- LeanBio Therapeutics, Inc., 2026-10-22, Brookline, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.